News & Analysis on Clinical Trial Services & Contract Research And Development
Akubio launches its pioneering acoustic detection technology for analysis of biomolecular interactions, which has been optimised for protein-protein interaction analysis that forms a crucial part of drug development.
Kemwell has sealed the deal on the purchase of Pfizer's Swedish manufacturing plant and at the same time secured a long-term contract manufacturing agreement with the drug giant.
New workflow technology can go a long way in ensuring security and traceability of data transfer prior to print in the pharmaceutical industry, avoiding errors that can potentially lead to life-threatening misinformation.
Outsourcing has become so paramount in a pharmaceutical's infrastructure and drug discovery strategy that it can no longer be considered an option, according to a Bristol Myers Squibb (BMS) senior scientist.
A warning letter from the US Food and Drug Administration (FDA) censuring Actavis for failing to file periodic safety reports at its solid oral dose manufacturing facility in New Jersey and not reporting adverse drug events has forced the company to...
Researchers have identified a diagnostic marker that they think could prove useful in gauging the effectiveness of anti-angiogenic drugs marking the first time that biomarkers have been defined for this drug class.
Diabetes experts have warned that urgent action needs to be taken to drastically improve the management of diabetes to prevent a potentially devastating and costly global burden.
Roche has boosted annual manufacturing capacity for Tamiflu (oseltamivir phosphate) to 80m treatment courses, as demand for the flu drug shows no sign of abating.
Zeiss has introduced its system to visualise the processes that occur at the cell membrane by delivering technology that delivers three unique features previously unseen on similar machines.
Nabi Biopharmaceuticals has obtained the exclusive rights to use a plasma protein purification technology from ProMetic Life Sciences in the large-scale development and manufacture of its hyperimmune products, cutting production costs and increasing...